EMRNEUTRAL

Revenue Growth (YoY)

2.9%

Updated 176h ago

Sector Performance

22th percentile

EMR

2.9%

Sector Median

7.9%

Sector Avg

11.7%

📊

Deep Analysis

Revenue Growth (YoY) measures the percentage increase in a company’s sales compared to the same period one year earlier; EMR’s 2.9% means its revenue barely grew over the prior year.

This lagged its sector, where the median growth was 8.0%, placing EMR at the 22nd percentile among peers—well below average. The trend data are not available (year-over-year change and quarter-over-quarter change are both listed as “N/A”), so no directional pattern can be assessed from prior periods. Without a trend, the low level alone signals a below-peer growth rate, which may point to weaker market share or demand, raising caution rather than opportunity. This metric contradicts the overall NEUTRAL verdict, as the company’s revenue growth is markedly below the sector median and in a low percentile, suggesting underperformance that a neutral rating does not fully capture.

Frequently Asked Questions

What does the Revenue Growth (YoY) tell investors about EMR?

Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.

How is the Revenue Growth (YoY) calculated?

Revenue Growth (YoY) is calculated as: (Revenue_t - Revenue_t-4) / Revenue_t-4.

Who are EMR's closest peers by Revenue Growth (YoY)?

The closest peers by Revenue Growth (YoY) include: COP (-4.6%), CCI (-4.8%), EMN (-4.9%), IPG (-5.1%), LEN (-5.2%).

The Formula

(Revenue_t - Revenue_t-4) / Revenue_t-4

Why It Matters

Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.